Silence Therapeutics

NASDAQ: SLN · Real-Time Price · USD
6.05
0.21 (3.60%)
At close: Jun 02, 2025, 11:45 AM

Silence Therapeutics Revenue

Silence Therapeutics reported an annual revenue of $43.26M, reflecting a 70.47% growth. For the quarter ending March 31, 2025, Silence Therapeutics generated $142K in revenue.
Revenue (ttm)
$43.26M
Revenue Growth
70.47%
Price / Sales Ratio
7.51
Revenue / Employee
$372.91K
Employees
116
Market Cap
285.98M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.